US Patent Issued to NovaGo Therapeutics on June 23 for "Anti-Nogo-A antibodies and methods of making and using thereof" (Swiss, German Inventors)

ALEXANDRIA, Va., July 15 -- United States Patent no. 12,662,528, issued on June 23, was assigned to NovaGo Therapeutics AG (Schlieren, Switzerland).

"Anti-Nogo-A antibodies and methods of making and using thereof" was invented by Benoit Combaluzier (Schlieren, Switzerland), Eduardo Paulo Morawski Vianna (Lorrach, Germany) and Michael Andreas Maurer (Schlieren, Switzerland).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided are novel human-derived monoclonal neutralizing Nogo-A specific antibodies as well as fragments, derivatives and variants thereof as well as methods related thereto. Polynucleotides, vectors, host cells and kits related to the Nogo-A specific antibodies are also provided. The antibodie...